Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Yu MC
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=2.787
------>paper_class3=2
------>paper_class2=1
------>vol=X
------>confirm_bywho=sheujr
------>insert_bywho=wc_ko
------>Jurnal_Rank=35.2
------>authors4_c=
------>comm_author=1
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=0
------>page2=7
------>medlineContent=
------>unit=E0106
------>insert_date=20091109
------>iam=5
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=-10000
------>journal_name=Eur J Pharmacol (doi 10.1016/j-ejphar.2009.10.031, in press)
------>paper_name=Luteolin, a non-selective competitive inhibitor of phosphodiesterases 1~5, displaced [3H]-rolipram from high-affinity rolipram binding sites and reversed xylazine/ketamine-induced anesthesia
------>confirm_date=20091109
------>tch_id=054002
------>pmid=no found
------>page1=1
------>fullAbstract=no found
------>tmu_sno=None
------>sno=22903
------>authors2=Chen JH
------>authors3=Lai CY
------>authors4=Han CY
------>authors5=Ko WC
------>authors6=
------>authors6_c=
------>authors=Yu MC
------>delete_flag=0
------>SCI_JNo=75229
------>authors2_c=
------>publish_area=0
------>updateTitle=no found
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=X
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2009
------>submit_flag=None
------>publish_month=11
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z